At the NIH State-of-the-Science Conference a few weeks ago, anindependent panel advised that active surveillance is appropriatefor patients presenting low-grade, low-volume prostate cancer andrecommended the removal of the terminology ‘cancer’ by physicianswhen discussing courses of action.While active surveillance forthese patients unarguably has many merits, Drs. Bruce Chabner andMatthew Smith of Massachusetts General Hospital expressed theirconcerns for the suggested change in...